Skyscape Web Viewer : Physicians' Cancer Chemotherapy Drug Manual : Classification Index

View All
Adrenal steroid inhibitor
ALK/RON inhibitor
ALK inhibitor Alectinib Brigatinib
Alkylating agent
Anthracycline Daunorubicin Doxorubicin Epirubicin Mitoxantrone Daunorubicin Liposome Doxorubicin liposome Idarubicin
Antiandrogen Apalutamide Enzalutamide Nilutamide Bicalutamide Flutamide
Anti angiogenic agent Lenalidomide Pomalidomide Lenvatinib Thalidomide
Antibody drug conjugate Ado-trastuzumab emtansine Brentuximab Gemtuzumab ozogamicin Loncastuximab tesirine-lpyl Polatuzumab vedotin Trastuzumab deruxtecan Belantamab mafodotin-blmf Enfortumab vedotin-ejfv Inotuzumab ozogamicin Mirvetuximab soravtansine-gynx Tisotumab vedotin-tftv
Anti CD19 antibody
Anti CD20 antibody Ofatumumab Rituximab-abbs Rituximab-pvvr Rituximab Rituximab and human hyaluronidase Tositumomab
Anti CD20 monoclonal antibody Ibritumomab Obinutuzumab Mosunetuzumab
Anti CD22 immunotoxin
Anti CD38 monoclonal antibody Daratumumab Daratumumab and Hyaluronidase-fihj
Anti CD52 monoclonal antibody
Anti CTLA4 monoclonal antibody
Anti EGFR MET bispecific monoclonal antibody
Adrenolytic agent
ALK and ROS1 inhibitor
Amti HER2 antibody
Anthracycline and antimetabolite
Anti angiogenesis agent
Antibody drug conjugate (ADC)
Anti CD19 monoclonal antibody
Anti CD22 antibody
Anti CD38 directed monoclonal antibody
Anti CTLA4 antibody
Anti EGFR antibody
Anti EGFR monoclonal antibody Cetuximab Necitumumab
Antiestrogen Tamoxifen Toremifene
Antifolate analog